Skip to content
Fencer Intel
critical 9.8

CVE-2015-3953 json

Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and…

published 7y ago modified 4mo ago also EUVD-2015-3984

cvss
9.8
version 3.0, NVD
cisa kev
Not listed
not in CISA's catalog
epss
2.0%
EPSS 2.0% chance of exploitation in 30 days, percentile 80%
public exploits
0
none known

Summary

Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Is CVE-2015-3953 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSA-15-161-01 updated cvss 10.0

Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities

  • Hospira Plum A+ Infusion System <=13.4 Hospira Plum A+3 Infusion System <=13.6 Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. Accordi <=3.13
    affected: mitigation “For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

1.97% chance of exploitation in the next 30 days, higher than 80% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
NVD 3.0 9.8 CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
NVD 2.0 10.0 AV:N/AC:L/Au:N/C:C/I:C/A:C

Affected products

  • Hospira Plum A+ Infusion System
  • Hospira Plum A+3 Infusion System
  • Hospira Symbiq Infusion System

Classification

Weakness
  • CWE-259 Use of Hard-coded Password
  • CWE-798 Use of Hard-coded Credentials

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.